For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
VEQSGDPTPPTAFGIEKSRVGEAVVVTVSGELDMLTAPRLAEMLRTSLIEAPATLIVDLSKVDFLASAGM TVLVSAKAQAVAPTRFVVVADGPATSRPIRLMGIDAMLPLYDALDDALNDISDS*
Operon Prediction Model: Genebank
Paralogs
| species | id | gene | e-value | identity (len) | annotation |
| M. marinum M | MMAR_0214 | - | - | 100% (125) | hypothetical protein MMAR_0214 |
| M. marinum M | MMAR_5181 | - | 7e-21 | 44.44% (99) | anti-anti-sigma regulatory factor |
| M. marinum M | MMAR_2800 | - | 4e-06 | 25.00% (116) | hypothetical protein MMAR_2800 |
Closest Orthologs (e-value cutoff: 1e-4)
| species | id | gene | e-value | identity (len) | annotation |
| M. bovis AF2122 / 97 | Mb3712c | - | 4e-11 | 41.43% (70) | hypothetical protein Mb3712c |
| M. gilvum PYR-GCK | Mflv_2021 | - | 9e-22 | 48.54% (103) | anti-sigma-factor antagonist |
| M. tuberculosis H37Rv | Rv3687c | rsfB | 5e-16 | 38.14% (97) | anti-anti-sigma factor RSFB (anti-sigma factor antagonist) |
| M. leprae Br4923 | - | - | - | - | - |
| M. abscessus ATCC 19977 | MAB_2512 | - | 1e-05 | 29.79% (94) | hypothetical protein MAB_2512 |
| M. avium 104 | MAV_5272 | - | 1e-36 | 61.79% (123) | anti-anti-sigma factor |
| M. smegmatis MC2 155 | MSMEG_6127 | - | 9e-26 | 49.11% (112) | anti-anti-sigma factor |
| M. thermoresistible (build 8) | TH_0498 | - | 4e-22 | 49.48% (97) | anti-anti-sigma factor |
| M. ulcerans Agy99 | MUL_2925 | - | 3e-06 | 25.00% (116) | hypothetical protein MUL_2925 |
| M. vanbaalenii PYR-1 | Mvan_3003 | - | 4e-21 | 48.48% (99) | anti-sigma-factor antagonist |
CLUSTAL 2.0.9 multiple sequence alignment
Mb3712c|M.bovis_AF2122/97 --------------------------------------------------
Rv3687c|M.tuberculosis_H37Rv ------------------------MSAPDSITVTVADHNGVAVLSIGGEI
MMAR_0214|M.marinum_M -----------MVEQS------GDPTPPTAFGIEKSRVGEAVVVTVSGEL
MAV_5272|M.avium_104 -----------MGEQP------GDLADPTPFEVGKHQVDQAVVLTVSGEV
TH_0498|M.thermoresistible__bu -------------------------------VIDERWDADIAVVSATGVV
Mvan_3003|M.vanbaalenii_PYR-1 -----------MDEQAAEGTNVGGAASSSTCVVTERWVERTAVVAVSGVV
MSMEG_6127|M.smegmatis_MC2_155 -----------MTSQ-----------DPANCTVEERRVGDITVVAVTGTV
Mflv_2021|M.gilvum_PYR-GCK -----------------------------MQQFTEREVDGVVIVAAVGAI
MUL_2925|M.ulcerans_Agy99 ---MNTVAMGSSPSSSSTRLSSPAGDPHTGLRAVTECTGSAVVVHVGGDV
MAB_2512|M.abscessus_ATCC_1997 MSVIDQNASRFAARAKTGVVSLFSSADDTARFTAHWHRPSAVLVRATGEI
Mb3712c|M.bovis_AF2122/97 -----------------MADNPTALVIDLSAVEFLGSVGLKILAATSEKI
Rv3687c|M.tuberculosis_H37Rv DLITAAALEEAIG--EVVADNPTALVIDLSAVEFLGSVGLKILAATSEKI
MMAR_0214|M.marinum_M DMLTAPRLAEMLR--TSLIEAPATLIVDLSKVDFLASAGMTVLVSAKAQA
MAV_5272|M.avium_104 DMLSSPMLAEAVQ--TALAAKPAALIVDLSKVGFLASAGMTVLVTTQAEL
TH_0498|M.thermoresistible__bu DMLSAPQLDEAIR--TALGKKPRALVVDFTAVDFLASAGMGVLVAIHDEV
Mvan_3003|M.vanbaalenii_PYR-1 DMLTSPQLESAID--TALSQQPAAVVIDFTDVEFLASAGMGVLVAAHDKA
MSMEG_6127|M.smegmatis_MC2_155 DMLTAPKLEDAIG--SAAKSEPSAVVVDLSAVDFLASAGMGVLVAAHGEL
Mflv_2021|M.gilvum_PYR-GCK DMLTAPQLQEAVA--AAARRRPSGLVVDLTSVDFLGSAGMQVLMETRKGL
MUL_2925|M.ulcerans_Agy99 DASNEVVWQRLVNRSAAIAIAPGPFVIDIRDLDFIGSCAYAVLAQESVRC
MAB_2512|M.abscessus_ATCC_1997 DAVNANHLAEYAT---RYLDGHRTLVLDLQGLRFFGTDGLVALDRVRRHC
.::*: : *:.: . *
Mb3712c|M.bovis_AF2122/97 GQ-SVKFGVVARGSVTRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR
Rv3687c|M.tuberculosis_H37Rv GQ-SVKFGVVARGSVTRRPIHLMGLDKTFRLFSTLHDALTGVRGGRIDR
MMAR_0214|M.marinum_M VA-PTRFVVVADGPATSRPIRLMGIDAMLPLYDALDDALNDISDS----
MAV_5272|M.avium_104 QP-PTKFAVVADGSATSRPIKLMGIDSVLSLYPSLNDALSALSGA----
TH_0498|M.thermoresistible__bu SP-AVNLTIVADGPATSRPLKLLGIADLVPLHATLDEALAAVAT-----
Mvan_3003|M.vanbaalenii_PYR-1 GS-DVKISVVAEGPATSRPLKLVGIADIVALYPNLEEALAARDT-----
MSMEG_6127|M.smegmatis_MC2_155 AP-AVRLVVVADGPATSRPLKLVGIADVVDLFATLDEALSSLKT-----
Mflv_2021|M.gilvum_PYR-GCK DG-DTRFAVVADGPATSRPLKITGITDYVDLYPSLDVALADLAG-----
MUL_2925|M.ulcerans_Agy99 RRRGVNLRLVSNQPIVARTIAACGLRRLLPMYSSVEAALSPVPNGH---
MAB_2512|M.abscessus_ATCC_1997 KVQGIDWTVIP-GDAVTKLLTLSGDMAAYPVNDAIPDVWKKLAQ-----
::. . : : * : : .